7Palermo B, Campanelli R, Garbelli S, et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gpl00 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathog
8Lang KS, Caroli CC, Muhm A, et al. HLA - A2 restricted, melanocyte-specific CD8 ( + ) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol, 2001, 116:891 - 897.
9Sreekumar GP, Erf GF, Smyth JR Jr. 5 - azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo. Clin Immunol Immunopathol,1996, 81:136 - 144.
10van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA- 4 ) and granulocyte/macrophage colony-stimulating factor (GM-CSF) -producing vaccines induces rejection of subcuta
2Do JE,Shin JY, Kim DY, et al. The effect of 308nm exeimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed, 2011,27 ( 3 ) : 147- 151.
3Alghamdi KM, Moussa NA, Mandil A, et al. Public perceptions and atti- tudes toward vitiligo[ J]. J Cutan Med Surg,2012,16(5) :334-340.
4Basak PY, Adiloglu AK, Ceyhan AM, et al. The role of helper and regu- latory T cells in the pathogenesis of vitiligo[ J]. J Am Acad Dermatol, 2009,60(2) :256-260.
5Wang CQ, Cruz-Inigo AE,Fuentes-Duculan J,et al. Thl7 cells and ac- tivated dendritic cells are increased in vitiligo lesions [ J ]. PLoS One, 2011,6(4) :e18907.
6Klarquist J, Denman C J, Hernandez C, et al. Reduced skin homing by functional Treg in vitiligo[ J]. Pigment Ceils Melanoma Res,2010,23 (2) :276-286.
7Zhang XY, He YL, Dong J, et al. Clinical efficacy of a 308 nm excimer laser in the treatment of vitiligo [ J ]. Photodermatol Photoimmunol Pho- tomed,2010,26 ( 3 ) : 138-142.
